| Literature DB >> 23839200 |
Martina Kerscher1, Yana Yutskovskaya, Timothy Corcoran Flynn.
Abstract
IncobotulinumtoxinA (Xeomin®/Xeomeen®/Bocouture®/XEOMIN Cosmetic™) is a botulinum toxin type A that differs from other commercially available botulinum toxin type A preparations in that it is free from complexing proteins ([150 kDa]/NT 201). The proven efficacy of incobotulinumtoxinA in various therapeutic indications preceded its use in the field of esthetic medicine, where it is widely approved for the treatment of glabellar frown lines on the basis of positive efficacy and safety findings from a number of clinical trials. Here, we discuss the characteristics of incobotulinumtoxinA and review the clinical data supporting its use in esthetics.Mesh:
Substances:
Year: 2013 PMID: 23839200
Source DB: PubMed Journal: J Drugs Dermatol ISSN: 1545-9616 Impact factor: 2.114